http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106668619-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_459f485a5ec6c3a54cae33be63b1f746 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-8994 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-64 |
| filingDate | 2015-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2048c5336140e87990f4618e21363053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6342d2ab932a750615dee22442456c30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6112acc78a12cf02e4286e749f76216d |
| publicationDate | 2017-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106668619-A |
| titleOfInvention | Hui nationality traditional Chinese medicine galla chinensis liver cancer resistant tablet and preparation method thereof |
| abstract | The invention discloses a formula of a Hui nationality traditional Chinese medicine galla chinensis liver cancer resistant tablet and a preparation method of the liver cancer resistant tablet. The liver cancer resistant tablet belongs to a green high-tech Chinese herbal medicine product for treating a liver cancer, is a traditional Chinese medicine tablet formed by mixing Chinese herbal medicines, such as galla chinensis, mutouhui, radix arnebiae lithospermi, radix stephaniae tetrandrae and thallus laminariae eckloniae according to a certain ratio, boiling with water, extracting, concentrating and tabletting, mainly treats the liver cancer, also treats digestive system cancers, such as a pharyngolaryngeal cancer, a stomach cancer and a colorectal cancer, and has the characteristics that drug tastes and doses are moderate, selected drugs are proved, through modern medical pharmacological experiments, to be capable of treating cancers, and through adoption of the liver cancer tablet, the physical function is fundamentally improved at low cost, the deterioration of diseases is controlled, and health is regained. |
| priorityDate | 2015-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 77.